Olympus (OTCMKTS:OCPNY) Shares Pass Above 50 Day Moving Average – Should You Sell?

Olympus Co. (OTCMKTS:OCPNY)’s stock price passed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $18.00 and traded as high as $18.00. Olympus shares last traded at $18.00, with a volume of 400 shares traded.

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group upgraded Olympus to a “buy” rating in a research report on Monday, May 18th. One equities research analyst has rated the stock with a Buy rating, Based on data from MarketBeat, Olympus presently has an average rating of “Buy”.

Olympus Stock Down 1.4%

The stock has a 50-day moving average of $18.00 and a two-hundred day moving average of $18.00. The company has a market cap of $23.15 billion, a P/E ratio of 21.95, a P/E/G ratio of 1.07 and a beta of 0.70. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.48 and a current ratio of 1.99.

About Olympus

Olympus Corporation is a Tokyo-headquartered manufacturer specializing in medical and scientific imaging, precision optics and related equipment. The company’s medical systems business is focused on endoscopic technologies and therapeutic devices used in minimally invasive diagnosis and treatment, supplying hospitals and clinical facilities with endoscopes, visualization platforms and accessories. In addition to healthcare, Olympus serves scientific and industrial customers with microscopes, imaging systems, non-destructive testing equipment and precision measurement tools used in research, manufacturing and quality control.

In recent years the company completed a strategic refocus on healthcare and scientific solutions, divesting its consumer camera business in 2020 to concentrate resources on medical device development, services and life-science applications.